31 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
written notice that the FDA (or applicable foreign equivalent), any other Governmental Authority or any institutional review board, ethics committee
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
)
Excluded Shares
2.1(b)
FCPA
FDA
3.21(c)
FDA Ethics Policy
3.21(i)
FDCA
3.21(a)
First Merger
Recitals
Form S-4
5.5(a)
Fractional Share Consideration
S-4/A
v292uif s7tqt828vdy
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
bsgp73
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
g79id
16 Jun 23
Business combination disclosure
8:08am
425
a6bb4e545dlf7 mm3m9
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
mfwkrj
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-10.1
ixqs2u0ts ivqsnx
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am